CAMTA1

Chr 1AD

calmodulin binding transcription activator 1

Also known as: CANPMR, CECBA

The protein encoded by this gene contains a CG1 DNA-binding domain, a transcription factor immunoglobulin domain, ankyrin repeats, and calmodulin-binding IQ motifs. The encoded protein is thought to be a transcription factor and may be a tumor suppressor. However, a translocation event is sometimes observed between this gene and the WWTR1 gene, with the resulting WWTR1-CAMTA1 oncoprotein leading to epithelioid hemangioendothelioma, a malignant vascular cancer. [provided by RefSeq, Mar 2017]

OMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 0.171 OMIM phenotype
Clinical SummaryCAMTA1
🧬
Gene-Disease Validity (ClinGen)
cerebellar dysfunction with variable cognitive and behavioral abnormalities · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.17LOEUF
pLI 1.000
Z-score 7.37
OE 0.09 (0.050.17)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
3.26Z-score
OE missense 0.71 (0.670.76)
725 obs / 1017.9 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.09 (0.050.17)
00.351.4
Missense OE?0.71 (0.670.76)
00.61.4
Synonymous OE?0.96
01.21.6
LoF obs/exp: 7 / 76.6Missense obs/exp: 725 / 1017.9Syn Z: 0.71
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveCAMTA1-related cerebellar dysfunction with variable cognitive and behavioural abnormalitiesLOFAD

This gene — mechanism propensity

DN
0.2997th %ile
GOF
0.3094th %ile
LOF
0.80top 5%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 1 literature citation · LOEUF 0.17 · ClinGen HI: Sufficient evidence for dosage pathogenicity

Literature Evidence

LOFHere, we show that global or nervous system deletion of CAMTA1 in mice causes severe ataxia with Purkinje cell degeneration and cerebellar atrophy, partially resembling the consequences of haploinsufficiency of the human CAMTA1 locus.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 25049392

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

CAMTA1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →